This inventor holds 1 USPTO granted patent. Top assignee: Incyte Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Innovations of Xuejun Chen in PI3K Related Disorders
Introduction
Xuejun Chen is a notable inventor based in Glen Mills, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of PI3K related disorders. His innovative approach has led to the development of effective methods that utilize pyrazolopyrimidine derivatives.
Latest Patents
Xuejun Chen holds 1 patent for his work titled "Dosing regimen for the treatment of PI3K related disorders." This patent outlines methods for treating disorders associated with PI3Kδ, showcasing his commitment to advancing medical science.
Career Highlights
Currently, Xuejun Chen is employed at Incyte Corporation, where he continues to push the boundaries of pharmaceutical research. His work at Incyte has positioned him as a key player in the development of innovative treatments.
Collaborations
Throughout his career, Xuejun Chen has collaborated with esteemed colleagues such as Albert Assad and Krishnaswamy Yeleswaram. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Xuejun Chen's contributions to the treatment of PI3K related disorders exemplify the impact of innovative thinking in medicine. His dedication to research and collaboration continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile